Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Sorrento Therapeutics Inc (NASDAQ:SRNE)

5.55
Delayed Data
As of Feb 17
 -0.075 / -1.33%
Today’s Change
4.62
Today|||52-Week Range
8.35
+13.27%
Year-to-Date
Insider Buys Shares of Sorrento Therapeutics
Feb 15 / GuruFocus News - Paid Partner Content
 

Today’s Trading

Previous close5.63
Today’s open5.65
Day’s range5.50 - 5.65
Volume100,755
Average volume (3 months)202,836
Market cap$325.9M
Dividend yield--
Data as of 3:59pm ET, 02/17/2017

Growth & Valuation

Earnings growth (last year)+4.62%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)+20.00%
P/E ratioNM
Price/Sales70.04
Price/Book1.44

Competitors

 Today’s
change
Today’s
% change
OMEDOncoMed Pharmaceutic...+0.06+0.69%
SVASinovac Biotech Ltd+0.01+0.18%
CCXIChemoCentryx Inc+0.21+3.07%
NERVMinerva Neuroscience...-0.05-0.50%
Data as of 4:00pm ET, 02/17/2017

Financials

Next reporting dateMarch 1, 2017
EPS forecast (this quarter)-$0.50
Annual revenue (last year)$4.6M
Annual profit (last year)-$45.8M
Net profit margin-998.06%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Henry H. Ji
Chief Operating Officer &
Executive Vice President
Jeffrey Su
Corporate headquarters
San Diego, California

Forecasts


Search for Jobs